Rapid Detection of Intracellular p47phox and p67phox by Flow Cytometry; Useful Screening Tests for Chronic Granulomatous Disease

被引:0
|
作者
Taizo Wada
Masahiro Muraoka
Tomoko Toma
Tsuyoshi Imai
Tomonari Shigemura
Kazunaga Agematsu
Kohei Haraguchi
Hiroyuki Moriuchi
Tsutomu Oh-ishi
Toshiyuki Kitoh
Osamu Ohara
Tomohiro Morio
Akihiro Yachie
机构
[1] School of Medicine,Department of Pediatrics
[2] Institute of Medical,Department of Pediatrics
[3] Pharmaceutical and Health Sciences,Department of Pediatrics
[4] Kanazawa University,Department of Pediatrics
[5] Otsu Red-Cross Hospital,Division of Infectious Diseases, Immunology, and Allergy
[6] Shinshu University School of Medicine,Department of Pediatrics
[7] Nagasaki University Hospital,Department of Pediatrics
[8] Saitama Children’s Medical Center,undefined
[9] Aichi Medical University,undefined
[10] Kazusa DNA research Institution,undefined
[11] Tokyo Medical and Dental University,undefined
来源
关键词
Chronic granulomatous disease; p47phox; p67phox; flow cytometry; screening test;
D O I
暂无
中图分类号
学科分类号
摘要
Chronic granulomatous disease (CGD) is caused by defects of NADPH oxidase. The diagnosis of CGD can be made by analysis of NADPH oxidase activity, however, identification of the CGD subgroups is required before performing mutation analysis. The membrane-bound subunits, gp91phox and p22phox, can be quickly analyzed by flow cytometry, unlike the cytosolic components, p47phox and p67phox. We evaluated the feasibility of flow cytometric detection of p47phox and p67phox with specific monoclonal antibodies in two patients with p47phox deficiency and 7 patients with p67phox deficiency. Consistent with previous observations, p47phox and p67phox were expressed in phagocytes and B cells, but not in T or natural killer cells, from normal controls. In contrast, patients with p47phox and p67phox deficiency showed markedly reduced levels of p47phox and p67phox, respectively. These techniques will be useful to rapidly assess the expression of the cytosolic components, p47phox and p67phox, and represents important secondary screening tests for CGD.
引用
收藏
页码:857 / 864
页数:7
相关论文
共 50 条
  • [41] The pivotal role of PKC-β activation in enhancing oxidative stress of diabetic glomeruli via p47phox and p67phox membrane translocation
    Kitada, M
    Koya, D
    Kashiwagi, A
    Haneda, M
    DIABETES, 2003, 52 : A187 - A187
  • [42] NCF1 (p47phox)-deficient chronic granulomatous disease: comprehensive genetic and flow cytometric analysis
    Kuhns, Douglas B.
    Hsu, Amy P.
    Sun, David
    Lau, Karen
    Fink, Danielle
    Griffith, Paul
    Huang, Wei
    Priel, Debra A. Long
    Mendez, Laura
    Kreuzburg, Samantha
    Zerbe, Christa S.
    De Ravin, Suk See
    Malech, Harry L.
    Holland, Steven M.
    Wu, Xiaolin
    Gallin, John, I
    BLOOD ADVANCES, 2019, 3 (02) : 136 - 147
  • [43] Architecture of the p40-p47-p67phox complex in the resting state of the NADPH oxidase -: A central role for p67phox
    Lapouge, K
    Smith, SJM
    Groemping, Y
    Rittinger, K
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (12) : 10121 - 10128
  • [44] Preclinical evaluation of the pCCLCHIM-p47 lentiviral vector for the gene therapy of p47phox deficient Chronic Granulomatous Disease
    Schejtman, A.
    Vetharoy, W.
    Choi, U.
    Rothe, M.
    Rivat, C.
    Piras, G.
    Benedetti, S.
    Santos, C. C.
    Schambach, A.
    Malech, H. L.
    Thrasher, A. J.
    Santilli, G.
    HUMAN GENE THERAPY, 2019, 30 (11) : A80 - A80
  • [45] Diabetes and Cardiovascular Disease in p47phox-/- Chronic Granulomatous Disease
    Leiding, Jennifer W.
    Marciano, Beatriz E.
    DeRavin, Suk See
    Malech, Harry L.
    Holland, Steven M.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 (02) : 389 - 389
  • [46] P40phox associates with the neutrophil Triton X-100-insoluble cytoskeletal fraction and PMA-activated membrane skeleton:: a comparative study with P67phox and P47phox
    El Benna, J
    Dang, PMC
    Andrieu, V
    Vergnaud, S
    Dewas, C
    Cachia, O
    Fay, M
    Morel, F
    Chollet-Martin, S
    Hakim, J
    Gougerot-Pocidalo, MA
    JOURNAL OF LEUKOCYTE BIOLOGY, 1999, 66 (06) : 1014 - 1020
  • [47] Analysis of a p67phoxΔ401 mutant identified in chronic granulomatous disease:: Deletion of C-terminal SH3 binding site for p47phox still supports NADPH oxidase activity in cosphox cells.
    Arias, AA
    Matute, JD
    Patino, PJ
    Dinauer, MC
    BLOOD, 2004, 104 (11) : 654A - 654A
  • [48] Novel human homologues of p47phox and p67phox participate in activation of superoxide-producing NADPH oxidases (vol 278, pg 25234, 2003)
    Takeya, Ryu
    Ueno, Noriko
    Kami, Keiichiro
    Taura, Masahiko
    Kohjima, Motoyuki
    Izaki, Tomoko
    Nunoi, Hiroyuki
    Sumimoto, Hideki
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (10) : 6003 - 6003
  • [49] Exploring the arachidonic acid-induced structural changes in phagocyte NADPH oxidase p47phox and p67phox via thiol accessibility and SRCD spectroscopy
    Bizouarn, Tania
    Karimi, Gilda
    Masoud, Rawand
    Souabni, Hager
    Machillot, Paul
    Serfaty, Xavier
    Wien, Frank
    Refregiers, Matthieu
    Houee-Levin, Chantal
    Baciou, Laura
    FEBS JOURNAL, 2016, 283 (15) : 2896 - 2910
  • [50] Towards clinical application of a lentiviral gene therapy protocol for p47phox deficient chronic granulomatous disease
    Schejtman, A.
    Aragao-Filho, W. C.
    Clare, S.
    Weisser, M.
    Zinicola, M.
    Burns, S.
    Thomas, D.
    Condino-Neto, A.
    Thrasher, A. J.
    Santilli, G.
    HUMAN GENE THERAPY, 2018, 29 (12) : A27 - A27